"The project will investigate the mechanism behind our recent breakthrough discovery that inhibition of the natural killer cell checkpoint prevents tumour metastasis and lethality. The project will indicate which cancers are most likely to respond to such therapy and guide our development of a drug fit for clinical trials."
– Dr Nicholas Huntington, cancer researcher at the Walter and Eliza Hall Institute.